SCHEMBL1285041

SCHEMBL1285041

CCOCc1cc2cc(Br)ccc2oc1=Nc1ccc(OC)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
AKR1B10 O60218 7/20 0.40
AKR1B1 P15121 7/20 0.40
POLB P06746 2/20 0.39
GPR55 Q9Y2T6 1/20 0.39
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 1/20 0.37
ALOX5 P09917 1/20 0.37
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
BACE1 P56817 1/20 0.36
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1285039 1.00 MAPT (0.41) MAPTSMN1; SMN2AKR1B10AKR1B1POLB
SCHEMBL1285742 0.92 MAOA (0.36) MAPTSMN1; SMN2AKR1B10AKR1B1ALDH1A1
SCHEMBL1285743 0.92 MAOA (0.36) MAPTSMN1; SMN2AKR1B10AKR1B1ALDH1A1
SCHEMBL1285076 0.89 LMNA (0.38) MAPTNPC1RAB9ATP53ALDH1A1
SCHEMBL1285073 0.89 LMNA (0.38) MAPTNPC1RAB9ATP53ALDH1A1
SCHEMBL1285421 0.88 MAPT (0.44) MAPTSMN1; SMN2POLBGPR55NPC1
SCHEMBL1285423 0.88 MAPT (0.44) MAPTSMN1; SMN2POLBGPR55NPC1
SCHEMBL1285495 0.88 LMNA (0.37) MAPTALOX5ALDH1A1LMNAHTT
SCHEMBL1285494 0.88 LMNA (0.37) MAPTALOX5ALDH1A1LMNAHTT
SCHEMBL1285424 0.88 MAOA (0.34) SMN1; SMN2TP53ALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383843-B2 Method for preparing a coumarin compound, chromene compound, and method for preparing a chromene compound KAOHSIUNG MEDICAL UNIVERSITY (TW) 2013-02-26 US disclosed
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND KAOHSIUNG MEDICAL UNIVERSITY (TW) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088923-A1 METHOD FOR PREPARING A COUMARIN COMPOUND, CHROMENE COMPOUND, AND METHOD FOR PREPARING A CHROMENE COMPOUND CYP3A7, CYP2A7, F7 MAPT 4232/4885SMN1; SMN2 4471/4885AKR1B10 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.